Background Residual slow pathway conduction in the form of persistent jump in the atrioventricular (AV) conduction time or atrial echo beats is a common finding after successful radiofrequency (RF) ablation of the slow pathway in patients with AV nodal reentrant tachycardia (AVNRT). Sites of successful RF ablation of the slow pathway may be located anteriorly in the tricuspid annulus (cephalad to the coronary sinus os) or posteriorly (at, within, or caudal to the coronary sinus os). The aim of this study was to investigate whether arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation.
Methods and Results Among 55 patients with symptomatic AVNRT having RF ablation, 23 patients (42%) (group 1) had evidence of persistent dual AV nodal pathway physiology and/or echo beats, whereas in 32 patients (group 2), slow pathway conduction had been completely eliminated. With regard to ablation sites, 14 patients (25%) (group A) had their slow pathway successfully ablated at an inferoposterior site, whereas in 41 patients (group B), the ablation site was located anteriorly to the coronary sinus os. The study patients included 17 men and 38 women, aged 37±18 years. The electrophysiological study and RF ablation were performed in a single session in 50 patients (91%). After the first session, the technique was successful in all patients (100%), with elimination of AVNRT and without affecting AV conduction. A mean M odification of the atrioventricular (AV) node without creating complete heart block can now be successfully accomplished with percutaneous techniques by use of radiofrequency (RF) energy in patients with AV nodal reentrant tachycardia (AVNRT), resulting in cure of the tachycardia by nonsurgical methods.'-" Of the two RF ablation techniques available for selective fast or slow pathway ablation,1,2 slow pathway ablation has been the preferred method due to lower risk of AV block.'1 Residual slow pathway conduction in the form of persistent jump in the AV conduction time or atrial echo beats is a common finding after successful RF ablation of the slow of 9+6 lesions were applied. The total procedure time averaged 4±1 hours. Fluoroscopy time was 41 +25 minutes. Except for transient AV block in 1 patient, no other complications occurred. Over 12±8 months, a total of 7 patients (13%) had recurrence of AVNRT, and 6 of them underwent successful repeat slow pathway RF ablation. Recurrence rate was 9% (2 patients) for group 1, with persistent jump or echo beats, and 16% (5 (Fig 2) .
Of the 55 patients undergoing slow pathway ablation, 23 patients (42%) constituted group 1, who had evidence of persistent dual AV nodal pathway physiology and/or echo beats at the end of the RF ablation procedure; group 2 comprised 32 patients in whom slow pathway conduction was completely eliminated. After slow pathway ablation, there was a significant increase in the AV block cycle length (from 346±38 to 390±47 milliseconds) and in the AV node effective refractory period (from 271±51 to 303 ±62 milliseconds), whereas the ventriculoatrial (VA) block cycle length did not change significantly (from 298±70 to 293±65 milliseconds). According to the site of successful ablation of the slow pathway, 14 patients assigned to group A (25%) had their slow pathway successfully ablated at an inferoposterior site (at or below the os of the coronary sinus); in 41 patients, constituting group B, the RE ablation was successful at a site located medially or anteriorly and superior to the coronary sinus os (Fig 1) .
During long-term clinical follow-up of 12+9 months, a total of 7 patients had recurrence of AVNRT. Clinical tachycardia recurrences were reported at 1 week (2 patients), 3 months (3 patients), and 6 months (2 patients) after the ablation. Six of these patients underwent successful repeat slow pathway ablation. The electrophysiological parameters before and after ablation were not significantly different in patients with and without recurrences. Before the ablation, the AV block cycle length was 340±58 milliseconds in patients with recurrences and 345±40 milliseconds in patients without recurrences; similarly, the VA block cycle length was 307±102 milliseconds in those with recurrences and 300±80 milliseconds in those without recurrences. The effective refractory period of the AV node was 263±111 milliseconds in the former and 270±55 milliseconds in the latter group. After ablation, the AV block cycle length was 373±53 and 380±50 milliseconds, respectively; the VA block cycle length was 312±105 and 295 ±70 milliseconds, and the effective refractory period was 317 ±95 and 305 ±60 milliseconds in the respective groups. The cycle length of the recurring AVNRT (328+±47 milliseconds) was similar to that of the initial tachycardia (343±70 milliseconds).
There was no significant difference in the number of recurrences between groups 1 and 2, with a 9% recurrence rate (2 of 23 patients) for group 1, with persistent jump or echo beats, and 16% for group 2 (5 of 32 patients), without residual slow pathway conduction (P=NS) ( Table 1) .
However, a significant difference was noted in the recurrence rate between groups A and B ( Table 2) . Five of the recurrences (71%) were noted in group A and 2 in group B. Thus, the recurrence rate was 36% for group A (5 of 14 patients), with posterior ablations, and 5% for group B (2 of 41 patients), with anterior sites of successful RF ablation (P<.05). With regard to the relation among the four groups, it was noted that among group 1 patients, 2 of 8 having their successful ablation at a posterior site and none of 15 patients having ablation at an anterior site had previous study has yet examined the relation of persistent slow pathway conduction or site of successful ablation with the rate of arrhythmia recurrence in these patients. The present study established a relation of tachycardia recurrences with the site of successful ablation but not with persistent slow pathway conduction (Tables 1 and 2 ). Significantly more recurrences were observed when the ablation site was located posteriorly (at or below the os of the coronary sinus) as compared with anterior locations. On the other hand, residual slow pathway conduction in the form of persistent jump in the AV conduction time or atrial echo beats did not correlate with tachycardia recurrences.
A degree of variability in the anatomic location of successful RF ablation of the slow pathway has been reported, with the most common site of successful slow pathway ablation described along the tricuspid annulus immediately anterior to the coronary sinus os (70% to 80%).3'5 Although anterior anatomic locations have been chosen by some investigators as the initial sites of slow pathway ablation,3 most prefer to start at posterior sites in an attempt to minimize the risk of injuring the AV node and causing AV block.2'6.1" However, according to the results of the present study, RF ablation at posterior sites is associated with a higher recurrence rate. It would therefore be preferable to choose more anterior sites as the initial targets and only if unsuccessful to move to inferoposterior locations. Because RF ablation was initiated posteriorly in the present study and was ended when successful, one cannot exclude the presence of other successful sites more anteriorly (cephalad to the coronary sinus os), which if identified first may confer a lower recurrence rate, as suggested by the results of the present study, a possibility that needs to be explored further. Only a prospective, randomized comparison of posterior versus anterior sites selected as initial targets of slow pathway ablation would clarify this issue. Such a study should also examine whether ablation at anterior sites is safe and does not increase the incidence of AV block. In the present study, the patient who developed transient AV block did have successful ablation at an anterior site.
In most studies, residual slow pathway conduction in the form of persistent jump in the AV conduction time or atrial echo beats is common after successful slow pathway RF ablation.2'4"5 [8] [9] [10] It has been intuitively believed that it is not necessary to eliminate all slow pathway conduction to successfully treat AVNRT, but one can end the procedure when AVNRT cannot be induced rather than aiming at eliminating all slow pathway conduction.59 Conversely, others target all slow pathway conduction and aim at eliminating any jump or AV nodal echo beats.36 The results of the present study support the view that it is not necessary to eliminate all slow pathway conduction for successful treatment of AVNRT and effective prevention of any recurrences. There was no higher incidence of tachycardia recurrences in patients with residual slow pathway conduction. On the contrary, more recurrences, although not at a statistically significant degree, were observed in patients with no residual slow pathway conduction. These results contrast with those of a recent report,14 whereby the tachycardia recurrence rate was higher in patients with residual slow pathway conduction. The routine use of isoproterenol infusion after ablation in our study may account for this discrepancy, as it probably facilitated the induction of AVNRT, which otherwise would have falsely denoted a successful ablation.
